Pancreatic Cancer Study
The Department of Radiation Oncology is conducting a study on doses of intensity-modulated radiotherapy (IMRT) in combination with chemotherapy in patients with unresectable pancreatic cancer. The purpose is to determine the maximum tolerable radiation dose delivered through the more advanced therapy technique, IMRT, while respecting the tolerance of healthy tissue. The long-term goal is to improve control of unresectable pancreatic cancer and quality of life.
Participants must meet the following criteria:
• Be 18 years or older and have proven carcinoma of the pancreas
• Have a tumor that is unresectable or medically inoperable
Participants will be excluded for the following criteria:
• Have a neuroendocrine tumor of the pancreas
• Have a history of abdominal radiation therapy
This is a partial list of inclusion and exclusion criteria. For more information, please contact Pierre Philippe at (312) 942-0739.
Is A Clinical Trial In Your Future?
Researchers at Rush University Medical Center are committed to finding new ways to prevent and treat disease. Among the dozens of ongoing studies are those on treatments for aging knees, spine problems and other bone and joint health issues. Ask your doctor about whether you would be a good candidate for a clinical trial. To find a list of clinical trials at Rush, visit the Clinical Trials home page.
Looking for a Doctor?
Rush University Medical Center in Chicago, Illinois, is a leader in caring for people of all ages, from newborns through older adults.
Just phone (888) 352-RUSH or (888) 352-7874 for help finding the doctor at Rush who’s right for you or your loved one.
Looking for Information About Other Medical Treatment and Services at Rush?